These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32674607)

  • 21. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of conjunctival melanoma].
    Salazar Méndez R; Baamonde Arbaiza B; de la Roz Martín P; Parra Rodríguez T
    Arch Soc Esp Oftalmol; 2014 Feb; 89(2):82-4. PubMed ID: 24269405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Conjunctival primary acquired melanosis].
    Krohn J; Monge OR
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
    Pe'er J; Frucht-Pery J
    Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Management of Squamous Cell Carcinoma of the Conjunctiva.
    Röck T; Bartz-Schmidt KU; Bramkamp M; Milla J; Bösmüller HC; Röck D
    Am J Case Rep; 2020 Feb; 21():e919751. PubMed ID: 32005796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of melanocytic conjunctival tumors.
    Halas JM; Svetlosakova Z; Babal P
    Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC; Shildkrot Y; Wilson MW
    Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
    Salomão DR; Mathers WD; Sutphin JE; Cuevas K; Folberg R
    Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection.
    Kikuchi I; Kase S; Ishijima K; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2271-2276. PubMed ID: 28752368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical management of circumscribed conjunctival melanomas.
    Shields JA; Shields CL; De Potter P
    Ophthalmic Plast Reconstr Surg; 1998 May; 14(3):208-15. PubMed ID: 9612814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH; Kim YH; Kim MS; Kim EC
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
    Schmidt M; Maier M; Schmidt T; Klaehsen D; Merté RL
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting recurrence and metastasis in conjunctival melanoma.
    Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
    Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AS-OCT Guided Treatment Of Diffuse Conjunctival Squamous Cell Carcinoma With Resection, Amniotic Membrane Graft And Topical Mitomycin C.
    Elhamaky TR; Elbarky AM
    Clin Ophthalmol; 2019; 13():2269-2278. PubMed ID: 31819351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excision with corneoscleral lamellar keratoplasty and amniotic membrane transplantation of a corneal displaced recurrent conjunctival melanoma.
    Kim EC; Kim MS; Kang NY
    Korean J Ophthalmol; 2012 Oct; 26(5):383-7. PubMed ID: 23060726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
    Khong JJ; Muecke J
    Br J Ophthalmol; 2006 Jul; 90(7):819-22. PubMed ID: 16672325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions.
    Nuessle S; Auw-Haedrich C; Jiang J; Boehringer D; Reinhard T
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1159-1166. PubMed ID: 36255550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma.
    Shields CL; Naseripour M; Shields JA; Eagle RC
    Ophthalmology; 2002 Nov; 109(11):2129-33. PubMed ID: 12414427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.